Stockscreener 앱 받기
68.00
0.78%
0.41
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Disc Medicine Q1 Net Loss Widens - Moomoo
Disc Medicine (NASDAQ:IRON) Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Earnings Flash (IRON) Disc Medicine Posts Q1 Net Loss $1.65 a Share, vs. FactSet Est of $1.65 Loss - marketscreener.com
Disc Medicine (NASDAQ: IRON) posts wider Q1 loss but holds $730M cash - Stock Titan
Disc Medicine 1Q 2026: Net income $(63.5M), EPS $(1.65) — 10-Q Summary - TradingView
IRON: Phase 3 bitopertin trial enrollment completed; strong cash position supports pipeline into 2029 - TradingView
Disc Medicine finishes Phase 3 rare-disease trial, eyes Q4 data - Stock Titan
IRON: Net loss widened to $63.5M in Q1 2026 as bitopertin's FDA review was delayed for more data - TradingView
Disc Medicine (NASDAQ: IRON) posts Q1 2026 loss and advances late-stage trials - Stock Titan
How Investors Are Reacting To Disc Medicine (IRON) After FDA Letter Triggers Shareholder Investigation - simplywall.st
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are ... - Caledonian Record
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Avoiding Lag: Real-Time Signals in (IRON) Movement - Stock Traders Daily
Disc Medicine, Inc. $IRON Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Jennison Associates LLC Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.IRON - PR Newswire
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - lincolnjournal.com
Pictet Asset Management Holding SA Grows Stock Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (IRON) Projected to Post Earnings on Thursday - MarketBeat
IRON Investor News: If You Have Suffered Losses in Disc - GlobeNewswire
[ARS] Disc Medicine, Inc. SEC Filing - Stock Titan
Disc Medicine (NASDAQ: IRON) details 2026 proxy, pay and board votes - Stock Titan
ROSEN, A LONGSTANDING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - TMX Newsfile
Disc Medicine prices upsized securities offering to raise total $250M - MSN
Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers - MSN
Disc Medicine plunges on FDA complete response letter for bitopertin - MSN
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - TMX Newsfile
Will Insider 10b5-1 Sales and New ASCO Data Shift Disc Medicine's (IRON) Narrative? - Sahm
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Scott Coop
IRON Price Today: Disc Medicine, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Disc Medicine (NASDAQ:IRON) Upgraded at Wall Street Zen - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Disc Medicine Completes Key Phase 1b Study of DISC-0974 in CKD Anemia: What Investors Should Watch - TipRanks
Disc Medicine to present myelofibrosis trial data at ASCO meeting By Investing.com - Investing.com India
Discipline and Rules-Based Execution in IRON Response - Stock Traders Daily
Disc Medicine Insider Sells $380K in Stock Amid 70% One-Year Surge - Yahoo Finance
Disc Medicine to present myelofibrosis trial data at ASCO meeting - Investing.com
Disc Medicine, Inc. to Present RALLY-MF Trial Data on DISC-0974 at ASCO Annual Meeting 2026 - Quiver Quantitative
Disc Medicine announced that the Phase 2 clinical trial data of its drug DISC-0974 in patients with myelofibrosis-associated anemia (RALLY-MF) have been selected for an oral presentation at the annual meeting of the American Society of Clinical Oncology. - Bitget
Myelofibrosis anemia data lands ASCO oral presentation on June 2 - Stock Titan
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - TMX Newsfile
Short Interest in Disc Medicine, Inc. (NASDAQ:IRON) Rises By 21.4% - MarketBeat
0.78%
3.01%
자본화:
|
볼륨(24시간):